Leonard Sank, Director at ORAMED PHARMACEUTICALS INC. (ORMP), bought 25,000 shares at $2.95 ($73K) on 2019-09-09, disclosed to the SEC on 2019-09-11.
Open-market purchase of $73k ORMP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.90 | 15,000 | $44K | 59.6% |
| 2 | $2.95 | 10,000 | $30K | 40.4% |
| Total | $2.92 avg | 25,000 | $73K | 100% |
| Filing → |
| ORMP.OB | BUY | 2011-10-06 | $300K | — | Filing → |
| ORMP | BUY | 2008-01-17 | $5K | — | Filing → |
| ORMP | BUY | 2008-01-09 | $7K | — | Filing → |